ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,796.00
0.34%
S&P ASX All Technology
3,092.40
0.70%
Brent Oil
84.39
0.00%
US Dollar vs AUD
1.49678
0.00%
Bitcoin
64,050.94
-0.30%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. I MAB (IMAB)

  7. I MAB (IMAB) News

IMAB

I MAB (IMAB)

I MAB
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMAB
DateTimeSourceHeadlineSymbolCompany
06/06/202421:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
06/06/202421:00PR Newswire (US)I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical OfficerNASDAQ:IMABI MAB
05/06/202421:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
05/06/202421:00PR Newswire (US)I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal CancersNASDAQ:IMABI MAB
31/05/202407:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMABI MAB
24/05/202407:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
24/05/202407:05GlobeNewswire Inc.I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024NASDAQ:IMABI MAB
22/05/202421:00PR Newswire (US)I-Mab to Participate at the Jefferies Global Healthcare ConferenceNASDAQ:IMABI MAB
30/04/202421:00PR Newswire (US)I-MAB Filed 2023 Annual Report on Form 20-FNASDAQ:IMABI MAB
05/04/202422:00PR Newswire (US)I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:IMABI MAB
03/04/202407:01PR Newswire (US)I-Mab Announces Closing of the Divestiture of Business Operations in ChinaNASDAQ:IMABI MAB
15/03/202408:00PR Newswire (US)I-Mab Reports Full Year 2023 Financial Results and Business UpdateNASDAQ:IMABI MAB
10/02/202408:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMABI MAB
08/02/202422:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
07/02/202422:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
07/02/202422:00PR Newswire (US)I-Mab Signs Agreement to Divest its Assets and Business Operations in ChinaNASDAQ:IMABI MAB
07/02/202412:55Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IMABI MAB
06/02/202422:34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
05/01/202422:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
03/01/202409:08Dow Jones NewsADRs Slump; FLJ Group Declines 21%NASDAQ:IMABI MAB
29/12/202322:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
26/12/202322:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
02/12/202306:41Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:IMABI MAB
16/11/202322:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
07/11/202300:00PR Newswire (US)I-Mab Announces Participation at Jefferies and Piper Conferences in NovemberNASDAQ:IMABI MAB
02/11/202323:00PR Newswire (US)Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)NASDAQ:IMABI MAB
01/11/202323:00PR Newswire (US)I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023NASDAQ:IMABI MAB
16/10/202323:00PR Newswire (US)I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023NASDAQ:IMABI MAB
11/10/202302:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
10/10/202323:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
 Showing the most relevant articles for your search:NASDAQ:IMAB

Your Recent History

BIT
P1U2R7
NLBNPIT1U2R7 20240621 48
LSE
55PK
Res.mort.9 A2 S
POLO
FRONTBTC
Frontier Token
COIN
RITEUR
Uberstate Real Estate Investment
TSXV
HN
High North Resources Ltd.
NASDAQ
ACTDU
ArcLight Clean Transitio...
LSE
35JZ
Res.mtg 15 M1 A
ASX
3MFDA
3D Metal Forge
GATE
MAJOUSDT
Majo
LSE
AC86
Res Mtg 11 Nt35
LSE
80WW
Res.mtg 16 A2cs
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved